Help
RSS
API
Feed
Maltego
Contact
Domain > www.demantinvest.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-12-28
20.13.99.228
(
ClassC
)
Port 443
HTTP/1.1 200 OKDate: Wed, 31 Jan 2024 00:48:29 GMTContent-Type: text/html; charsetutf-8Content-Length: 15491Connection: keep-aliveCache-Control: no-cache, no-storePragma: no-cacheExpires: -1X-Frame-Op !DOCTYPE html SYSTEM about:legacy-compat>html classno-js langen data-cdn-base-path//wdh01.azureedge.net/>head>title> William Demant Invest A/S/title>meta http-equivX-UA-Compatible contentIEEdge/>meta nameviewport contentwidthdevice-width, initial-scale1.0/>meta charsetutf-8/>meta nameformat-detection contenttelephoneno/>meta propertyog:description contentWilliam Demant Invest A/S is an evergreen investment company, wholly owned by the charitable William Demant Foundation. William Demant Invest is the majority shareholder in Demant, Össur and Vision RT and has significant holdings in Vitrolife, CellaVision, Jeudan and Borkum Riffgrund 1. When investing in new companies, William Demant Invest generally looks for medtech/healthcare industries and strong underlying market factors such as demographic trends and structural growth./>meta propertyog:title contentWilliam Demant Invest A/S/>meta propertyog:url contenthttps://www.demantinvest.com//>meta namedescription contentWilliam Demant Invest A/S is an evergreen investment company, wholly owned by the charitable William Demant Foundation. William Demant Invest is the majority shareholder in Demant, Össur and Vision RT and has significant holdings in Vitrolife, CellaVision, Jeudan and Borkum Riffgrund 1. When investing in new companies, William Demant Invest generally looks for medtech/healthcare industries and strong underlying market factors such as demographic trends and structural growth./>meta nametwitter:title contentWilliam Demant Invest A/S/>meta nametwitter:description contentWilliam Demant Invest A/S is an evergreen investment company, wholly owned by the charitable William Demant Foundation. William Demant Invest is the majority shareholder in Demant, Össur and Vision RT and has significant holdings in Vitrolife, CellaVision, Jeudan and Borkum Riffgrund 1. When investing in new companies, William Demant Invest generally looks for medtech/healthcare industries and strong underlying market factors such as demographic trends and structural growth./>meta namei
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]